Literature DB >> 22009001

Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris.

Haiqin Zhu1, Yayuan Chen, Yun Zhou, Ying Wang, Jie Zheng, Meng Pan.   

Abstract

Pemphigus vulgaris (PV) is a Th2-dominant autoimmune skin disease. We showed that indeed active PV patients had a biased Th2 response and specific IgG4 autoantibodies were dominant. To further investigate the role of antigen-specific Th2 cells in the regulation of pathogenic Dsg3-IgG antibody production, we used recombined Dsg3 protein to immunize wild-type C57BL/6 mice with aluminum hydroxide or complete Freund's adjuvant as adjuvant. CD4(+) T cells from Dsg3-immunized mice were adoptively transferred into TCR-β chain deficient mice. The transferred CD4(+) T cells were readily seen in the peripheral blood and spleen, and interacted with B cells, resulting in B-cell activation. Furthermore, transferred CD4(+) T cells from mice immunized with Dsg3 plus Alum with Th2 phenotype were able to render unprimed B cells to secrete Dsg3-specific IgG1 antibody in vivo. Taken together, these results provide the first demonstration of direct role of Dsg3-reactive CD4(+) T (Th2) cells in the regulation of pathologic anti-Dsg3 antibody production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009001     DOI: 10.1007/s10875-011-9597-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  29 in total

1.  Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.

Authors:  M Sekiguchi; Y Futei; Y Fujii; T Iwasaki; T Nishikawa; M Amagai
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

Review 2.  Pemphigus: autoimmunity to epidermal cell adhesion molecules.

Authors:  M Amagai
Journal:  Adv Dermatol       Date:  1996

3.  Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.

Authors:  M S Lin; S J Swartz; A Lopez; X Ding; M A Fernandez-Vina; P Stastny; J A Fairley; L A Diaz
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.

Authors:  K Nishifuji; M Amagai; M Kuwana; T Iwasaki; T Nishikawa
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

Review 5.  Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion.

Authors:  J R Stanley
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

Review 6.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

7.  T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.

Authors:  Christian M Veldman; Kerstin L Gebhard; Wolfgang Uter; Ralf Wassmuth; Joachim Grötzinger; Erwin Schultz; Michael Hertl
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 8.  Immunoglobulin G4: an odd antibody.

Authors:  R C Aalberse; S O Stapel; J Schuurman; T Rispens
Journal:  Clin Exp Allergy       Date:  2009-02-13       Impact factor: 5.018

Review 9.  Desmosomes and disease: pemphigus and bullous impetigo.

Authors:  Aimee S Payne; Yasushi Hanakawa; Masayuki Amagai; John R Stanley
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

Review 10.  The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.

Authors:  Cassian Sitaru; Sidonia Mihai; Detlef Zillikens
Journal:  Arch Dermatol Res       Date:  2007-02-03       Impact factor: 3.017

View more
  9 in total

1.  Glucocorticoid sensitivity and proinflammatory cytokines pattern in pemphigus.

Authors:  Rosangela Soares Chriguer; Ana Maria Roselino; Margaret de Castro
Journal:  J Clin Immunol       Date:  2012-03-10       Impact factor: 8.317

Review 2.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

Review 3.  A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris.

Authors:  Vincent Van Drongelen; Joseph Holoshitz
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

4.  Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls.

Authors:  Pegah Shahbazian; Maryam Izad; Maryam Daneshpazhooh; Hossein Mortazavi; Zahra Salehi; Shirin Behruzifar; Soheil Tavakolpour; Arghavan Azizpour
Journal:  Dermatol Pract Concept       Date:  2021-04-12

5.  Serum leptin levels in pemphigus: a case control study.

Authors:  Nikoo Mozafari; Reza M Robati; Shima Younespour
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

6.  Detection of rare autoreactive T cell subsets in patients with pemphigus vulgaris.

Authors:  Alexandra Polakova; Leonie Kauter; Adina Ismagambetova; Dario Didona; Farzan Solimani; Kamran Ghoreschi; Michael Hertl; Christian Möbs; Christoph Hudemann
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

7.  Regulatory effects of Nr4a2 on Th2 cells from patients with pemphigus vulgaris.

Authors:  Jianbo Chen; Yao Zhang; Yunsheng Liang; Ming Zhao; Hai Long; Rong Xiao; Haijing Wu; Jieyue Liao; Shuaihantian Luo; Guiying Zhang; Qianjin Lu
Journal:  Oncotarget       Date:  2018-02-01

Review 8.  Immune response patterns in non-communicable inflammatory skin diseases.

Authors:  K Eyerich; S Eyerich
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-15       Impact factor: 6.166

9.  Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?

Authors:  Roberto Russo; Emanuele Cozzani; Giulia Gasparini; Aurora Parodi
Journal:  Dermatol Ther       Date:  2020-01-02       Impact factor: 2.851

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.